AbbVie has filed for approval of its oral CGRP inhibitor Qulipta for prevention of chronic migraine, seeking to leap ahead of its main rival in the class.
A new type of drug that prompts the body’s muscles to absorb excess blood sugar could revolutionize the treatment of type 2 diabetes.
Stanford researchers and their colleagues have found a molecule that suppresses appetite after intense exercise.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.